KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $856000.0.

  • Oscar Health's Amortization of Deferred Charges rose 33897.44% to $856000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 million, marking a year-over-year increase of 10951.16%. This contributed to the annual value of $1.6 million for FY2025, which is 10951.16% up from last year.
  • Per Oscar Health's latest filing, its Amortization of Deferred Charges stood at $856000.0 for Q4 2025, which was up 33897.44% from $385000.0 recorded in Q3 2025.
  • Oscar Health's 5-year Amortization of Deferred Charges high stood at $856000.0 for Q4 2025, and its period low was $129000.0 during Q1 2022.
  • Its 5-year average for Amortization of Deferred Charges is $248705.9, with a median of $195000.0 in 2022.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first crashed by 6079.03% in 2022, then soared by 33897.44% in 2025.
  • Quarter analysis of 5 years shows Oscar Health's Amortization of Deferred Charges stood at $329000.0 in 2021, then tumbled by 41.03% to $194000.0 in 2022, then increased by 0.52% to $195000.0 in 2023, then changed by 0.0% to $195000.0 in 2024, then soared by 338.97% to $856000.0 in 2025.
  • Its Amortization of Deferred Charges was $856000.0 in Q4 2025, compared to $385000.0 in Q3 2025 and $195000.0 in Q2 2025.